NP / PA
Mclean, Andrea
Mclean, Andrea was paid $220K by Medicaid between Aug 2021 and Dec 2024, across 10 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoMCLEAN, ANDREA
BLOOMINGTON, IL 61705
BLOOMINGTON, IL 61705
33aNPI1265030019assigned 10/14/2020
33bProvider typeNurse Practitioner
28Total paid$220K
24GClaims5,063
24DCodes billed10
24AFirst – last monthAug 2021 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#138 of 1,687
Median peer was paid$22K
This provider vs. median10.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,083 | $33K | |
| 2022 | 1,588 | $69K | |
| 2023 | 1,278 | $54K | |
| 2024incomplete | 1,114 | $63K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 2,404 | 2,225 | $101K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 894 | 839 | $64K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.9% | 433 | 392 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.3% | 754 | 717 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.2% | 284 | 257 | $11K |
| 87428 | 3.8% | 132 | 126 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.3% | 72 | 72 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | 34 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 39 | 35 | $1K |
| 87807 | <1% | 17 | 15 | $171.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.